ÂÜÀòÂÒÂ×

Cheryl Beal Anderson is a seasoned professional in regulatory affairs and consulting with extensive experience in the biotech and pharmaceutical sectors. Currently serving as a consultant for biotech start-ups at Texas Medical Center Innovation since May 2023 and as the founder of ACE Regulatory Affairs Consulting since October 2022, Anderson has held significant leadership roles, including Sr./Vice President of Global Regulatory Affairs, Quality, and Drug Safety at Upsher-Smith Laboratories from April 2015 to May 2022. Prior experience includes positions as Senior Director at Lundbeck and Eli Lilly, focusing on regulatory development strategy and US regulatory affairs, respectively. Cheryl Beal Anderson holds an MBA in Pharmaceutical & Healthcare Marketing from Saint Joseph's University, a PharmD from The University of Texas at Austin, and a post-graduate clinical pharmacy residency in Psychiatry from UT Health San Antonio, along with two bachelor's degrees in Pharmacy and Biomedical Sciences.